Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Cardiotoxicity × Hematologic Tests × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Plasma cell 1 Other 1

Conditions

Venous Thromboembolism 1 Prostatic Neoplasms 1 Neuroblastoma 1 Neoplasms 1 Multiple Myeloma 1 Lung Neoplasms 1 Dyspnea 1 Cardiotoxicity 1 Adenocarcinoma of Lung 1

Interventions

Doxorubicin 3 Docetaxel 2 Cyclophosphamide 2 Trastuzumab 1 Neoadjuvant Therapy 1 Methotrexate 1 Leucovorin 1 High-Intensity Interval Training 1 Hematologic Tests 1 Filgrastim 1 Exercise 1 Epirubicin 1 Echocardiography 1 Dexrazoxane 1 Cisplatin 1 Chemotherapy, Adjuvant 1 Atorvastatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04827563 2026-03-04

Dyspnea and Cardiotoxicity in Multiple Myeloma Patients Who Receive Carfilzomib

University of Chicago

OtherPlasma cell

Dyspnea, Multiple Myeloma, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡